Unlike its rivals, which require weekly injections, MariTide offers the potential for monthly or less frequent dosing ...

Dengue fever is evolving to become more unpredictable and spread on a larger scale, heaping pressure on the healthcare system ...

The clinical trial published in JAMA involved around 300 Black African participants with uncontrolled hypertension in Nigeria ...

The autoclave market is set to grow from USD 2.2 billion in 2023 to USD 3.68 billion by 2034, achieving a CAGR of 4.7%.

European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine, led by its founder and renowned expert Prof. Mike Chan ...

For our methodology, we used a stock screener and selected healthcare stocks that had an RSI below 30, mid-market cap, and ...

Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

IMPORTANT PRECAUTIONS: Hypertension, including hypertensive crisis, may occur. Blood pressure should be measured prior to the initiation of FRUZAQLA treatment and periodically during this treatment; ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech Global Forum in London, UK. Since its ...

Genfit licensed Iqirvo's global rights to Ipsen in 2021, securing milestone payments and royalties. Read why GNFT stock's ...

Geojit Financial Services recommended accumulate rating on Biocon with a target price of Rs 376 in its research report dated ...

(Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company ... beyond the Company's control and which could, and likely will, materially affect actual ...